
|Articles|September 15, 2005
Glaucoma treatment costs present economic ramifications
Fort Lauderdale, FL—The economic ramifications of treating ocular hypertension and glaucoma bring some serious questions into the spotlight, notably the costs of treatment and especially the increased rate of cataract extractions associated with the use of anti-glaucoma eye drops. Harry Quigley, MD, considered these issues at the annual meeting of the Association for Research in Vision and Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
2
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
3
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
4
Study maps thermal dynamics of glaucoma laser treatments
5















































.png)


